AUTHOR=Belladonna Maria Laura , Orabona Ciriana TITLE=Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 JOURNAL=Frontiers in Pharmacology VOLUME=11 YEAR=2020 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.00959 DOI=10.3389/fphar.2020.00959 ISSN=1663-9812 ABSTRACT=

Tocilizumab has been proposed as a means of opposing hyperinflammatory responses in intensive care patients with COVID-19. Here, we briefly discuss the potentially multiple, synergistic mechanisms whereby tocilizumab might exert therapeutic activity, mostly focusing on the production of tryptophan-derived catabolites that would result from blockade of IL-6 signaling, as contextualized to the cytokine storm occurring in COVID-19 patients.